MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic...
Q1 2021
May 14, 2026
FY 2025
Dec 30, 2025
Q4 2020
Dec 31, 2020
Q2 2020
Jun 30, 2020
FY 2019
Dec 31, 2019